Category Specific RSS

Opinion

Will fears of the Wuhan Coronavirus continue to hamstring markets?

Today the Chinese Government announced that the number of Wuhan coronavirus infections had passed 20,000 people. So far, the virus has killed 425 of these individuals, with this number now greater than the number of fatalities from the SARS virus in China. Despite this, markets are rallying higher today, following a rebound in US markets overnight.

This rally has likely been supported by the injection of Chinese stimulus into markets and their economy, but despite this, risks persist.

If history is anything to go by, markets are likely to continue seeing selling until the net new cases of the virus has peaked; which is what happened under SARS and other notable viral outbreaks.

There is also much speculation that China is either deliberately or inadvertently under-reporting the true number of infections, with The Lancet, an international medical journal, publishing a report that estimates more than 75,000 infections in Wuhan alone. They also reported that “epidemics are already growing exponentially in multiple major cities of China with a lag time behind the Wuhan outbreak of about 1–2 weeks.”

The direct impacts of the virus are already starting to be seen. Energy prices are dropping substantially due to an expected drop in travel and freight due to the virus, travel bans are likely to reduce tourism, travel, education, and perhaps even retail sales, and all of this could damage listed companies and their earnings. The Reserve Bank of Australia (RBA) went as far in its statement today as to declare that the virus is ‘having a significant effect on the Chinese economy’.

Indeed, it has been reported that China is considering lowering its economic growth targets for calendar 2020 due to the negative impacts of the virus. The RBA also warned that the ‘coronavirus outbreak will temporarily weigh on [Australian] domestic growth’.

The longer and further the virus spreads, the greater the impact on the global economy. The greater the impact on the global economy and the more sensational the media coverage, the more selling we are likely to see in global markets.

Companies that have been immediately impacted by the virus, such as travel related stocks, have already seen some serious selling, but many of these stocks have rebounded today. Regardless, prominent investors, such as former PIMCO CEO Mohamed El-Erian, have warned that the virus could shake markets out of their current ‘buy-the-dip’ mentality.

Although we have not seen real market selling for some time, it may still pay to be cautious.

Sam Green

Sam Green is the Portfolio Manager at Emerald Financial, whilst also being an Equities and Derivatives expert for his clients at TradersCircle.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago